Remco van Doorn

Leiden University Medical Center

Netherlands

Research Interests

Explore related searches

Professors in Netherlands Professors in Immunology Immunology professors in Netherlands

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (3)

Jos van der Hage

Professor of Surgery

Leiden University Medical Center

NETHERLANDS

View details

Maarten Vermeer

Prof dr

Leiden University Medical Center

NETHERLANDS

View details

Alfred Vertegaal

Professor

Leiden University

NETHERLANDS

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Remco van Doorn

Research Interests

Explore related searches

Contact this professor

Articles (10)

Adverse Events in Anti-PD-1-Treated Adjuvant and First-Line Advanced Melanoma Patients

A disease-associated XPA allele interferes with TFIIH binding and primarily affects transcription-coupled nucleotide excision repair

Surveillance, CDKN2A and survival of familial melanoma.

Stratum corneum cytokine levels in mycosis fungoides

Therapeutic Strategies for Targeting CDKN2A Loss in Melanoma

Therapeutic Strategies for Targeting CDKN2A Loss in Melanoma

Stratum corneum cytokine levels in mycosis fungoides.

Ambiguous melanocytic lesions: A retrospective cohort study of incidence and outcome of melanocytic tumor of uncertain malignant potential (MELTUMP) and superficial atypical melanocytic proliferation of uncertain significance (SAMPUS) in the Netherlands.

Gene-Level Associations in Patients With and Without Pathogenic Germline Variants in <i>CDKN2A</i> and Pancreatic Cancer.

DOT1L inhibition does not modify the sensitivity of cutaneous T cell lymphoma to pan-HDAC inhibitors in vitro

Collaborators (3)

Jos van der Hage

Maarten Vermeer

Alfred Vertegaal

Make your next move.